These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The menopause: benefits and risks of estrogen-progestogen replacement therapy. Gambrell RD Fertil Steril; 1982 Apr; 37(4):457-74. PubMed ID: 7040116 [TBL] [Abstract][Full Text] [Related]
3. Comparative cardiovascular effects of different progestins in menopause. Rosano GM; Fini M Int J Fertil Womens Med; 2001; 46(5):248-56. PubMed ID: 11720197 [TBL] [Abstract][Full Text] [Related]
4. Effects of postmenopausal hormone replacement therapy on lipid, lipoprotein, and apolipoprotein (a) concentrations: analysis of studies published from 1974-2000. Godsland IF Fertil Steril; 2001 May; 75(5):898-915. PubMed ID: 11334901 [TBL] [Abstract][Full Text] [Related]
5. Association of hormone-replacement therapy with various cardiovascular risk factors in postmenopausal women. The Atherosclerosis Risk in Communities Study Investigators. Nabulsi AA; Folsom AR; White A; Patsch W; Heiss G; Wu KK; Szklo M N Engl J Med; 1993 Apr; 328(15):1069-75. PubMed ID: 8384316 [TBL] [Abstract][Full Text] [Related]
6. The metabolic impact of oral contraceptives. Krauss RM; Burkman RT Am J Obstet Gynecol; 1992 Oct; 167(4 Pt 2):1177-84. PubMed ID: 1415443 [TBL] [Abstract][Full Text] [Related]
7. Postmenopausal women and cardiovascular risk: impact of hormone replacement therapy. Rosano GM; Fini M Cardiol Rev; 2002; 10(1):51-60. PubMed ID: 11790270 [TBL] [Abstract][Full Text] [Related]
8. The varying effects of progestins on lipid levels and cardiovascular disease. La Rosa JC Am J Obstet Gynecol; 1988 Jun; 158(6 Pt 2):1621-9. PubMed ID: 3132043 [TBL] [Abstract][Full Text] [Related]
9. Estrogen and estrogen-progestogen replacement: therapy and cardiovascular diseases. Barrett-Connor E Am J Med; 1993 Nov; 95(5A):40S-43S. PubMed ID: 8256794 [TBL] [Abstract][Full Text] [Related]
10. Hormone replacement therapy and lipoprotein changes during early menopause. Egeland GM; Kuller LH; Matthews KA; Kelsey SF; Cauley J; Guzick D Obstet Gynecol; 1990 Nov; 76(5 Pt 1):776-82. PubMed ID: 2170887 [TBL] [Abstract][Full Text] [Related]
11. Can menopause be considered an independent risk factor for cardiovascular disease? Mercuro G; Zoncu S; Cherchi A; Rosano GM Ital Heart J; 2001 Oct; 2(10):719-27. PubMed ID: 11721715 [TBL] [Abstract][Full Text] [Related]
12. [Hormone replacement therapy and cardiovascular risk]. Maffei S; De Caterina R G Ital Cardiol; 1996 Aug; 26(8):899-940. PubMed ID: 9005173 [TBL] [Abstract][Full Text] [Related]
13. Changes in plasma lipoprotein and apolipoprotein composition in relation to oral versus percutaneous administration of estrogen alone or in cyclic association with utrogestan in menopausal women. Moorjani S; Dupont A; Labrie F; De Lignieres B; Cusan L; Dupont P; Mailloux J; Lupien PJ J Clin Endocrinol Metab; 1991 Aug; 73(2):373-9. PubMed ID: 1649840 [TBL] [Abstract][Full Text] [Related]
18. Estrogen replacement therapy and cardiovascular protection: lipid mechanisms are the tip of an iceberg. Nasr A; Breckwoldt M Gynecol Endocrinol; 1998 Feb; 12(1):43-59. PubMed ID: 9526710 [TBL] [Abstract][Full Text] [Related]
19. Estrogen and cardiovascular function after menopause. Samaan SA; Crawford MH J Am Coll Cardiol; 1995 Nov; 26(6):1403-10. PubMed ID: 7594062 [TBL] [Abstract][Full Text] [Related]
20. Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins. Walsh BW; Schiff I; Rosner B; Greenberg L; Ravnikar V; Sacks FM N Engl J Med; 1991 Oct; 325(17):1196-204. PubMed ID: 1922206 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]